ArticleCureus2025
From Vision Changes to Hospice: The Rapid Progression of Orbital Metastasis in Hepatocellular Carcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is an aggressive primary liver malignancy with a high potential for metastasis, commonly involving the lungs, bones, and lymph nodes. However, orbital metastasis is an exceptionally rare presentation. This case describes a 73-year-old man with a history of HCC, hypertension, type 2 diabetes with neuropathy, chronic obstructive pulmonary disease (COPD), hepatitis C, liver cirrhosis, and portal hypertension who presented with a two-week history of blurry vision in the left eye, numbness on the left forehead, and a sensation of orbital fullness. He also reported an episode of unintentional bilateral upper extremity jerking followed by nausea and vomiting. Examination revealed left-sided proptosis, and imaging identified a retrobulbar orbital mass with muscle involvement. Biopsy confirmed metastatic HCC. Despite an initial referral for Y-90 radiotherapy, the patient was unable to undergo treatment due to multiple hospitalizations for unrelated conditions. Following the diagnosis of orbital metastasis, he experienced rapid functional decline, including multiple falls, cognitive deterioration, and loss of independence in activities of daily living, ultimately requiring hospice care. This case underscores the importance of recognizing rare metastatic patterns in HCC, especially in patients presenting with ocular symptoms. It highlights the severe consequences of delayed cancer treatment and the critical role of coordinated care in managing complex patients. Clinicians must remain vigilant in identifying unusual symptoms in patients with HCC to facilitate early diagnosis and timely intervention for advanced metastatic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.